Related Experiment Videos
Waldenström's macroglobulinemia associated with AA amyloidosis
1Hematology Unit, Rabin Medical Center, Petah-Tikva, Israel.
International Journal of Hematology
|September 4, 2001
Summary
Amyloid A protein (AA) amyloidosis is rarely seen in Waldenström's macroglobulinemia (WM). This case report suggests AA amyloidosis may occur in WM patients, challenging the exclusive light-chain deposition theory.
Area of Science:
- Hematology
- Oncology
- Nephrology
Background:
- Waldenström's macroglobulinemia (WM) is a rare lymphoproliferative disorder.
- Amyloidosis in WM is typically attributed to amyloid light-chain (AL) deposition.
- Previous characterization of amyloid types in WM is limited.
Observation:
- A patient with WM presented with malabsorption, nephrotic syndrome, and orthostatic hypotension.
- Immunohistochemical analysis of a rectal biopsy confirmed amyloid A protein (AA) deposition.
- This represents the third reported case of AA amyloidosis in a patient with WM.
Findings:
- The study presents a case of Waldenström's macroglobulinemia associated with amyloid A protein (AA) amyloidosis.
- This finding challenges the long-held belief that only amyloid light-chain (AL) deposition causes amyloidosis in WM.
- The presence of AA amyloidosis in this WM patient is supported by immunohistochemical evidence.
Implications:
- The findings suggest that AA amyloidosis should be considered in the differential diagnosis of amyloidosis in WM patients.
- This broadens the understanding of potential amyloidogenic pathways in WM.
- Further investigation is warranted to determine the frequency and clinical significance of AA amyloidosis in WM.